1. Home
  2. PTHL vs DLHC Comparison

PTHL vs DLHC Comparison

Compare PTHL & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • DLHC
  • Stock Information
  • Founded
  • PTHL 1998
  • DLHC 1969
  • Country
  • PTHL China
  • DLHC United States
  • Employees
  • PTHL N/A
  • DLHC N/A
  • Industry
  • PTHL
  • DLHC Business Services
  • Sector
  • PTHL
  • DLHC Consumer Discretionary
  • Exchange
  • PTHL Nasdaq
  • DLHC Nasdaq
  • Market Cap
  • PTHL 85.4M
  • DLHC 79.6M
  • IPO Year
  • PTHL 2024
  • DLHC N/A
  • Fundamental
  • Price
  • PTHL $18.50
  • DLHC $5.88
  • Analyst Decision
  • PTHL
  • DLHC
  • Analyst Count
  • PTHL 0
  • DLHC 0
  • Target Price
  • PTHL N/A
  • DLHC N/A
  • AVG Volume (30 Days)
  • PTHL 1.0M
  • DLHC 107.7K
  • Earning Date
  • PTHL 02-11-2025
  • DLHC 07-30-2025
  • Dividend Yield
  • PTHL N/A
  • DLHC N/A
  • EPS Growth
  • PTHL N/A
  • DLHC 75.08
  • EPS
  • PTHL N/A
  • DLHC 0.38
  • Revenue
  • PTHL $448,196.00
  • DLHC $377,074,000.00
  • Revenue This Year
  • PTHL N/A
  • DLHC N/A
  • Revenue Next Year
  • PTHL N/A
  • DLHC N/A
  • P/E Ratio
  • PTHL N/A
  • DLHC $15.67
  • Revenue Growth
  • PTHL N/A
  • DLHC N/A
  • 52 Week Low
  • PTHL $1.32
  • DLHC $2.72
  • 52 Week High
  • PTHL $22.34
  • DLHC $11.99
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • DLHC 68.70
  • Support Level
  • PTHL N/A
  • DLHC $5.45
  • Resistance Level
  • PTHL N/A
  • DLHC $5.67
  • Average True Range (ATR)
  • PTHL 0.00
  • DLHC 0.20
  • MACD
  • PTHL 0.00
  • DLHC -0.01
  • Stochastic Oscillator
  • PTHL 0.00
  • DLHC 86.96

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About DLHC DLH Holdings Corp.

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.

Share on Social Networks: